Strain Rv6, a streptomycin-independent reverse mutant of Salmonella abortusovis, multiplied and disseminated in vivo to a lesser extent than the virulent parental strain 15/5, as determined by subcutaneous inoculation of two outbred strains of mice with different susceptibilities to salmonella infection. This lower virulence of strain Rv6 was not modified by 10 passages in susceptible mice. Vaccination with strain Rv6 induced a dose-dependent capacity of mice to control subsequent infection with the virulent parental strain. Induced resistance began as early as 3 days after vaccination and lasted at least 11 months. Its efficiency was controlled by different routes and doses of challenge. Strain Rv6 induced a greater protection than that conferred by heat-killed bacteria or by tested commercial killed vaccines.
Salmonella abortus-ovis is a pathogen specific for sheep and goats that induces abortion and, to a lesser degree, mortality of young (13) . Many European countries face difficulties in controlling this disease because there are no ways to diagnose all infected animals. Immunization would be one way to reduce losses and excretion of the bacteria at the time of parturition (13, 23) .
Because effective immunity against salmonellosis is not generally produced by dead vaccines (6, 31) , research has been oriented towards a live attenuated strain. Earlier successful vaccination trials against enterobacterial diseases (9, 17, 31) or sheep brucellosis (2, 10) motivated our choice of mutants for streptomycin. Isolation of such mutants and screening of their virulence and immunogenicity with a murine model were reported in a previous paper (16) . Subsequent experiments were conducted on sheep. They confirmed the low virulence of isolated mutants and demonstrated the efficiency of vaccination with strain Rv6, a streptomycin-independent reverse mutant (22, 24, 29) .
Vaccinal characteristics required of live vaccines are well-known: inocuousness, efficiency in inducing protection, and characteristics or markers that differentiate vaccinal mutant strains from wild-type virulent strains (14) . The aim of experiments on mice related in this paper was to assess the low virulence, stability, and immunogenicity of strain Rv6. Protection induced by strain Rv6 against challenge with virulent S. abortus-ovis was compared with that induced by killed vaccines and by primary infection with the parental virulent strain.
MATERIALS AND METHODS
Mice. Conventional female mice from two outbred Swiss strains were bred in a conditioned building (21°C, 60% relative humidity, filtered air) with free access to water and sterilized food. As already reported (16), CD-1 mice (Charles River Breeding Laboratories, Elbeuf, France) are more resistant to salmonella infection than OF1 mice (Iffa-Credo, St-Germain sur l'Arbresle, France).
Bacteria. S. abortus-ovis 15/5 and a streptomycinresistant strain derived from it were used for primary infection and challenge, respectively; both strains are of comparable virulence for mice (23) . Isolation of strain Rv6 was reported in a previous publication (16) The result of increasing the vaccinal dose of strain Rv6 in CD-1 and OF1 mice was to increase protection against subcutaneous inoculation with the fully virulent strain 15/5 (Fig. 3) . Vaccination with 108 Rv6 bacteria gave the greatest difference between controls and vaccinated mice; among the latter, no salmoneilae could be recovered from the spleens of 6 out of 10 OF1 mice and 8 out of 10 CD-1 mice.
Unlike live vaccine, heat-killed S. abortusovis induced non-dose-dependent protection against subcutaneous challenge. There was a difference of around 1 log10 between the levels of splenic infection in nonvaccinated controls and in mice immunized with different doses varying from 105 to 109 killed bacteria per mouse ( vaccination. Protection remained stable from day 7 after immunization until the end of the experiment 11 months later (Fig. 4) . Different doses of subcutaneous challenge were used to compare a commercial killed vaccine in oil adjuvant (108 bacteria per mouse) with the live strain Rv6 vaccine (108 bacteria per mouse) in their abilities to protect CD-1 and OF1 mice (Table 3 ). Live vaccine reduced the level of splenic infection more than killed vaccine did, but both types of immunization induced protection against death.
The transfer to recipient mice of immune sera from CD-1 mice immunized with strains Rv6 or 15/5 reduced the level of splenic infection by challenge bacteria in a similar manner (Table 4) . Titers of these two immune sera in agglutinins against S. abortus-ovis did not differ. In normal serum transferred as a control, antibodies specific for salmonellae could not be detected.
When challenged by the oral route with a high dose of virulent S. abortus-ovis, OF1 mice immunized with heat-killed bacteria from strains Rv6 or 15/5 showed no acquired resistance against infection (Table 5) . Immunization with living Rv6 bacteria significantly reduced the number of challenge organisms colonizing the spleen 6 days after inoculation.
DISCUSSION
The results reported in this paper provide evidence for the stability of the low virulence of strain Rv6 and its immunogenicity for CD-1 and OF1 mice. The low virulence of strain Rv6 was confirmed by the kinetics of infection in subcutaneously inoculated mice. As in intravenously inoculated OF1 mice (16) , control by the host of the vaccinal splenic infection occurred as early as 3 days after immunization. (25) . However, our model seemed sensitive enough to detect any virulent form. Such reversion was not observed. In addition, the virulence of strain Rv6 for mice was not modified when it was reisolated from the lymph nodes of vaccinated ewes, nor was it modified after seven successive cultures in a batch-type fermentor (unpublished data).
Strain Rv6 persisted 2 to 3 weeks in CD-1 mice and no longer than 1 month in OF1 mice, which are more susceptible to salmonella infection. Persistence was sufficient to confer on these strains of mice an early and long-lasting immunity, lasting much longer than the persistence of vaccinal bacteria in the host. This fact indicates the induction of an immunological memory (7).
Resistance to challenge as acquired by immunization with live or killed vaccine was assessed by comparing the rates of growth or inactivation of challenge organisms in spleens of different groups (6) . The results obtained by Germanier (12) , which were similar to those presented here and in a previous publication (16) , suggest that to produce good protection a vaccinal strain must induce a process that resembles bacterial colonization by wild-type strains. In mice vaccinated with strain Rv6 or infected for the first time with virulent strain 15/5, the mechanisms of resistance of challenge appeared to be similar in the following ways. (i) Immunization with either strain reduced the dissemination and multiplication of challenge organisms and increased the rate of their elimination from infected tissues.
(ii) Protection induced by strain Rv6 increased with the dose of immunization, as it does in the case of primary infection (23) . (iii) Antibody responses on similar levels were provoked by the administration of either strain; furthermore, sera from mice immunized with strain Rv6 and with 15/5 produced a similar level of protection against S. abortus-ovis when passively transferred to recipient mice. Therefore, the slightly higher immunogenicity of virulent strain 15/5 might be due more to quantitative than to qualitative factors, i.e., to the in vivo capacity of multiplication, dissemination, and persistence rather than to modifications of the cell wall (which may involve protecting antigens). But this hypothesis has not yet been properly investigated.
Our results, however, obtained with a particular serotype of S. abortus-ovis, confirm the superior efficacy of live over heat-killed salmonella vaccine (9, 12, 17) . The efficacy of live vaccine has been explained by residual multiplication in the host, in vivo development of a complete array of antigenic structures, or both, depending upon the importance attributed to humoral or cellular immunity in salmonellosis (6, 29) . In fact, control of bacterial infection involves at least three types of mechanisms, each essential for the survival of the host (28) . First, bacterial implantation is restricted by early nonspecific activities of macrophages (5, 20) and soluble factors of serum (11) . Second, salmonella dissemination and multiplication is delayed by antibodies specific for antigens from the cell wall, i.e., to a great extent for the lipopolysaccharides (8, 15, 19, 30) . In addition, it should be noted that an early synthesis of antibodies has been shown with various models (1, 4, 21) . Third, the development of a cell-mediated immunity, which coincides with control of infection by a normal nonimmunized host, enables the latter to eliminate bacteria from infected tissues (6, 18) . In the absence of complete Freund adjuvant, currently available killed vaccine, unlike live vaccines, seems unable to induce T-cell-mediated mechanisms of resistance (7) .
The results of our experiments on mice have been confirmed to a certain extent by experimental infection of pregnant ewes. When vaccinated with strain Rv6, ewes were protected against a subcutaneous challenge that provoked abortion in 90% of nonimmunized controls and in 60%o of the animals vaccinated with commercial killed vaccines (29) . These results confirm the efficiency of vaccination with a streptomycin-independent reverse mutant, which was first demonstrated fgainst brucellosis (2, 10). They make possible the development of a murine model of control (26) for the eventual commercial production of vaccine Rv6, the efficacy of which has now to be demonstrated in field experiments.
